Two years of newborn screening for cystic fibrosis in North Macedonia: First experience

1Smyth AR, Bell SC, Bojcin S, BryonM, Duff A, Flume P, et al. European Cystic Fibrosis Society standards of care: Best practice guidelines. J Cyst Fibros. 2014; 13(Suppl 1): S23-S42.Smyth AR Bell SC Bojcin S BryonM Duff A Flume P et al European Cystic Fibrosis Society standards of care: Best practice guidelines J Cyst Fibros 2014 13 Suppl 1 S23 S4210.1016/j.jcf.2014.03.010Search in Google Scholar

2Castellani C, Duff AJA, Bell SC, Heijerman HGM, Munck A, Ratjen F, et al. ECFS best practice guidelines: The 2018 revision. J. Cyst Fibros. 2018; 17(2): 153-178.Castellani C Duff AJA Bell SC Heijerman HGM Munck A Ratjen F et al ECFS best practice guidelines: The 2018 revision J. Cyst Fibros 2018 17 2 153 17810.1016/j.jcf.2018.02.006Search in Google Scholar

3Castellani C, Southern KW, Brownlee K, Roelse JD, Duff A, Farrell M, et al. European best practice guidelines for cystic fibrosis neonatal screening. J Cyst Fibros. 2009; 8(3): 153-173.Castellani C Southern KW Brownlee K Roelse JD Duff A Farrell M et al European best practice guidelines for cystic fibrosis neonatal screening J Cyst Fibros 2009 8 3 153 17310.1016/j.jcf.2009.01.004Search in Google Scholar

4Travert G, Heeley M, Heeley A. History of newborn screening for cystic fibrosis–The early years. Int J Neonatal Screen. 2020; 6(1): 8.Travert G Heeley M Heeley A History of newborn screening for cystic fibrosis–The early years Int J Neonatal Screen 2020 6 1 810.3390/ijns6010008Search in Google Scholar

5Scotet V, Gutierrez H, Farrell PM. Newborn screening for CF across the globe– Where is it worthwhile? Int J Neonatal Screen. 2020; 6(1): 18.Scotet V Gutierrez H Farrell PM Newborn screening for CF across the globe– Where is it worthwhile? Int J Neonatal Screen 2020 6 1 1810.3390/ijns6010018Search in Google Scholar

6Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, et al.; Cystic Fibrosis Foundation. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic fibrosis foundation consensus report. J Pediatr. 2008; 153(2): S4-S14.Farrell PM Rosenstein BJ White TB Accurso FJ Castellani C Cutting GR et al Cystic Fibrosis Foundation. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic fibrosis foundation consensus report J Pediatr 2008 153 2 S4 S1410.1016/j.jpeds.2008.05.005Search in Google Scholar

7Farrell PM, White TB, Howenstine MS, Munck A, Parad RB, Rosenfeld M, et al. Diagnosis of cystic fibrosis in screened populations. J Pediatr. 2017; 181(Suppl): S33-S44.e2.Farrell PM White TB Howenstine MS Munck A Parad RB Rosenfeld M et al Diagnosis of cystic fibrosis in screened populations J Pediatr 2017 181 Suppl S33 S44 .e210.1016/j.jpeds.2016.09.065Search in Google Scholar

8Noveski P, Madjunkova S, Mircevska M, Plaseski T, Filipovski V, Plaseska-Karanfilska D. SNaPshopt assay for the detection of the most common mutations in infertile men. PLoS One. 2014; 9(11): e112498.Noveski P Madjunkova S Mircevska M Plaseski T Filipovski V Plaseska-Karanfilska D SNaPshopt assay for the detection of the most common mutations in infertile men PLoS One 2014 9 11 e11249810.1371/journal.pone.0112498Search in Google Scholar

9Terzic M, Jakimovska M, Fustik S, Jakovska T, Sukarova-Stefanovska E, Plaseska-Karanfilska D. Cystic fibrosis mutation spectrum in North Macedonia: A step toward personalized therapy. Balkan J Med Genet. 2019; 22(1): 35-40.Terzic M Jakimovska M Fustik S Jakovska T Sukarova-Stefanovska E Plaseska-Karanfilska D Cystic fibrosis mutation spectrum in North Macedonia: A step toward personalized therapy Balkan J Med Genet 2019 22 1 35 4010.2478/bjmg-2019-0009Search in Google Scholar

10Naehrlich L. The changing face of cystic fibrosis and its implications for screening. Int J Neonatal Screen. 2020; 6(3): 54.Naehrlich L The changing face of cystic fibrosis and its implications for screening Int J Neonatal Screen 2020 6 3 5410.3390/ijns6030054Search in Google Scholar

11Farrell PM, Kosorok MR, Rock MJ, Laxova A, Zeng L, Lai HC, et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics. 2001; 107(1): 1-13.Farrell PM Kosorok MR Rock MJ Laxova A Zeng L Lai HC et al Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics 2001 107 1 1 1310.1542/peds.107.1.1Search in Google Scholar

12Mak DYF, Sykes J, Stephenson AL, Lands LC. The benefits of newborn screening for cystic fibrosis: The Canadian experience. J Cyst Fibros. 2016; 15(3): 302-308.Mak DYF Sykes J Stephenson AL Lands LC The benefits of newborn screening for cystic fibrosis: The Canadian experience J Cyst Fibros 2016 15 3 302 30810.1016/j.jcf.2016.04.001Search in Google Scholar

13Siret D, Bretaudeau G, Branger B, Dabadie A, Dagorne M, David V, et al. Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: A 10-year retrospective study in a French region (Brittany). Pediatr Pulmonol. 2003; 35(5): 342-349.Siret D Bretaudeau G Branger B Dabadie A Dagorne M David V et al Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: A 10-year retrospective study in a French region (Brittany) Pediatr Pulmonol 2003 35 5 342 34910.1002/ppul.10259Search in Google Scholar

14Schluter DK, Southern KW, Dryden C, Diggle P, Taylor-Robinson D. Impact of newborn screening on outcomes and social inequalities in cystic fibrosis: A UK CF registry-based study. Thorax. 2020; 75(2): 123-131.Schluter DK Southern KW Dryden C Diggle P Taylor-Robinson D Impact of newborn screening on outcomes and social inequalities in cystic fibrosis: A UK CF registry-based study Thorax 2020 75 2 123 13110.1136/thoraxjnl-2019-213179Search in Google Scholar

15Davies G, Stocks J, Thia LP, Hoo A-F, Bush A, Aurora P, et al. Pulmonary function deficits in newborn screened infants with cystic fibrosis managed with standard UK care are mild and transient. Eur Respir J. 2017; 50(5): 1700326.Davies G Stocks J Thia LP Hoo A-F Bush A Aurora P et al Pulmonary function deficits in newborn screened infants with cystic fibrosis managed with standard UK care are mild and transient Eur Respir J 2017 50 5 170032610.1183/13993003.00326-2017Search in Google Scholar

16Tridello G, Castellani C, Meneghelli I, Tamanini A, Assael BM. Early diagnosis from newborn screening maximises survival in severe cystic fibrosis. ERJ Open Res. 2018; 4(2): 00109-2017.Tridello G Castellani C Meneghelli I Tamanini A Assael BM Early diagnosis from newborn screening maximises survival in severe cystic fibrosis ERJ Open Res 2018 4 2 00109 201710.1183/23120541.00109-2017Search in Google Scholar

17Nshimyumukiza L, Bois A, Daigneault P, Lands L, Laberge AM, Fournier D, et al. Cost effectiveness of newborn screening for cystic fibrosis: A simulation study. J Cyst Fibros. 2014; 13(3): 267-274.Nshimyumukiza L Bois A Daigneault P Lands L Laberge AM Fournier D et al Cost effectiveness of newborn screening for cystic fibrosis: A simulation study J Cyst Fibros 2014 13 3 267 27410.1016/j.jcf.2013.10.012Search in Google Scholar

18Castellani C, Massie J, Sontag M, Southern KW. Newborn screening for cystic fibrosis. Lancet Respir Med. 2016; 4(8): 653-661.Castellani C Massie J Sontag M Southern KW Newborn screening for cystic fibrosis Lancet Respir Med 2016 4 8 653 66110.1016/S2213-2600(16)00053-9Search in Google Scholar

19Barben J, Castellani C, Dankert-Roelse J, Gartner S, Kashirskaya N, Linnane B, et al. The expansion and performance of national newborn screening programmes for cystic fibrosis in Europe. J Cyst Fibros. 2017; 16(2): 207-213.Barben J Castellani C Dankert-Roelse J Gartner S Kashirskaya N Linnane B et al The expansion and performance of national newborn screening programmes for cystic fibrosis in Europe J Cyst Fibros 2017 16 2 207 21310.1016/j.jcf.2016.12.012Search in Google Scholar

20Munck A, Mayell SJ, Winters V, Shawcross A, Derichs N, Parad R, et al. Cystic fibrosis screen positive, inconclusive diagnosis (CFSPID): A new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening. J Cyst Fibros. 2015; 14(6): 706-713.Munck A Mayell SJ Winters V Shawcross A Derichs N Parad R et al Cystic fibrosis screen positive, inconclusive diagnosis (CFSPID): A new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening J Cyst Fibros 2015 14 6 706 71310.1016/j.jcf.2015.01.001Search in Google Scholar

21Southern KW, Barben J, Gartner S, Munck A, Castellani C, Mayell SJ, et al. Inconclusive diagnosis after a positive newborn bloodspot screening result-for cystic fibrosis; clarification of the harmonised international definition. J Cyst Fibros. 2019; 18(6): 778-780.Southern KW Barben J Gartner S Munck A Castellani C Mayell SJ et al Inconclusive diagnosis after a positive newborn bloodspot screening result-for cystic fibrosis; clarification of the harmonised international definition J Cyst Fibros 2019 18 6 778 78010.1016/j.jcf.2019.04.010Search in Google Scholar

22Munck A. Inconclusive diagnosis after newborn screening for cystic fibrosis. Int J Neonatal Screen. 2020; 6(1): 19.Munck A Inconclusive diagnosis after newborn screening for cystic fibrosis Int J Neonatal Screen 2020 6 1 1910.3390/ijns6010019Search in Google Scholar

23Rusakow LS, Frank J, Accurso FJ. Immunoreactive trypsinogen levels in infants with cystic fibrosis complicated by meconium ileus. Screening. 1993; 2: 13-17.Rusakow LS Frank J Accurso FJ Immunoreactive trypsinogen levels in infants with cystic fibrosis complicated by meconium ileus Screening 1993 2 13 1710.1016/0925-6164(93)90013-9Search in Google Scholar

24Repeto T, Mergni G, Revenni N, Zavataro L, Braggion C. Delay in meconium emission: Should it be considered a risk for cystic fibrosis. [Abstract 46]. J Cyst Fibros. 2011; 11(Suppl 1): S12-S46.Repeto T Mergni G Revenni N Zavataro L Braggion C Delay in meconium emission: Should it be considered a risk for cystic fibrosis [Abstract 46]. J Cyst Fibros 2011 11 Suppl 1 S12 S4610.1016/S1569-1993(11)60066-0Search in Google Scholar